Up to 60% off Profit Pro - Limited Time Offer!
Winter Sale

60% off Profit Pro - Limited Time Offer!

Appili Therapeutics Inc

Appili Therapeutics Inc

APLIF Β· PINK
APLIF Β· PINK

Next Earnings: 11 Feb 2025

0.03
USD00.00%

Analysts Recommendations

Bearish

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Day Range

0.03USD
0.03USD

52 Week Range

0.01USD
0.05USD

Market Cap

3.15MUSD

About

General Information

Type

Common Stock

Exchange

PINK

Currency Code

USD

Currency Name

US Dollar

Country Name

USA

Country ISO

US

ISIN

CA03783R1073

CUSIP

-

Sector

Healthcare

Industry

Biotechnology

Fiscal Year End

March

IPO date

-

Updated At

-

Highlights

PE Ratio

-

PEG Ratio

-

Book Value

-0.09

Dividend Share

-

Dividend Yield

-

Earnings Share

-0.02

Wall Street Target Price

0.15

EPS Estimate Current Year

0

EPS Estimate Next Year

0

EPS Estimate Current Quarter

0

EPS Estimate Next Quarter

0

Most Recent Quarter

-

Profitability

Revenue TTM

827,407

Gross Profit TTM

1,390,684

EBITDA

-8,590,420

Profit Margin

0.00%

Return On Assets TTM

-244.22%

Return On Equity TTM

-938.72%

Revenue Per Share TTM

0.007

Qtly Revenue Growth YOY

-96.50%

Diluted Eps TTM

-0.02

Qtly Earnings Growth YOY

0.00%

Valuation

Trailing PE

0.00

Forward PE

1

Price Sales TTM

9.3018

Price Book MRQ

1.4792

Enterprise Value Revenue

28

Enterprise Value EBITDA

-2

Peers analysis

  • CSL Ltd
    CSLLYCSL Ltd

    88.70

    1.04%
  • Vertex Pharmaceuticals Inc
    VRTXVertex Pharmaceuticals Inc

    409.80

    0.46%
  • argenx NV ADR
    ARGXargenx NV ADR

    632.04

    0.33%
  • Regeneron Pharmaceuticals Inc
    REGNRegeneron Pharmaceuticals Inc

    716.68

    0.31%
  • argenx SE
    ARGNFargenx SE

    630.00

    0.00%
  • CSL Limited
    CMXHFCSL Limited

    173.50

    0.00%
  • UCB SA
    UCBJFUCB SA

    198.28

    0.00%
  • UCB SA ADR
    UCBJYUCB SA ADR

    99.02

    -0.96%
  • Alnylam Pharmaceuticals Inc
    ALNYAlnylam Pharmaceuticals Inc

    241.31

    -0.88%
  • BioNTech SE
    BNTXBioNTech SE

    113.30

    -0.54%